Red Light Holland Closes Majority Stake in Acadian Exotic Mushrooms, Partnering with Leading Canadian Fresh and Dried Mushroom Producers on East Coast Facility Post published:September 7, 2021 Post category:Press Release
Mindset Pharma Develops Highly Specialized Preclinical Rodent Trained Studies with Its Drugs to Differentiate Between Their Psychedelic and Non-Psychedelic Effects Post published:September 7, 2021 Post category:Press Release
Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose Post published:September 7, 2021 Post category:Press Release
Nova Mentis Expands Psilocybin Research Program Targets Obesity and Diabetes Post published:September 7, 2021 Post category:Press Release
Filament Health Shares to Commence Trading on the OTC Market Post published:September 7, 2021 Post category:Press Release
Mydecine Innovations Group Announces MYCO-001 Seamless Phase 2/3 Smoking Cessation Clinical Trial Post published:September 7, 2021 Post category:Press Release
Psychedelic Bulletin: DEA Proposes Increase to Psilocybin Quota; Field Trip Launches KAP Co-Operative Program; MindMed Files DTx Patent Application Post published:September 3, 2021 Post category:Psychedelic Bulletin
MindMed and BioXcel Therapeutics Publish an International Patent Application Describing a System for Identifying Agitation Episodes Post published:September 2, 2021 Post category:Press Release
Red Light Holland Successfully Completes Canada’s Largest Legal Sale and Import of Psilocybe Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit Post published:September 1, 2021 Post category:Press Release
Filament Health Files 20th Patent Application Including Three International PCT Applications Post published:September 1, 2021 Post category:Press Release